125 related articles for article (PubMed ID: 22216500)
1. Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics.
Willey RF; Grant IW; Pocock SJ
Br J Clin Pharmacol; 1976 Aug; 3(4):595-600. PubMed ID: 22216500
[TBL] [Abstract][Full Text] [Related]
2. A study with cumulative doses of formoterol and salbutamol in children with asthma.
Foucard T; Lönnerholm G
Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, crossover comparison of carbuterol and salbutamol.
Guleria JS; Vasu KV; Pande JN
Ann Allergy; 1979 Aug; 43(2):123-5. PubMed ID: 380412
[TBL] [Abstract][Full Text] [Related]
4. Inhaled procaterol versus salbutamol in bronchial asthma.
Liippo K; Silvasti M; Tukiainen H
Eur J Clin Pharmacol; 1991; 40(4):417-8. PubMed ID: 1828765
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma.
Kruse M; Rosenkranz B; Dobson C; Ayre G; Horowitz A
Pulm Pharmacol Ther; 2005; 18(3):229-34. PubMed ID: 15707858
[TBL] [Abstract][Full Text] [Related]
6. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
Ence TJ; Tashkin DP; Ho D; Child JS
Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
[TBL] [Abstract][Full Text] [Related]
7. Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma.
Beumer HM
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):237-9. PubMed ID: 381220
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
Völkl KP; Kroll VM; Wiesemann HG; Schneider B
Arzneimittelforschung; 1991 May; 41(5):533-6. PubMed ID: 1680327
[TBL] [Abstract][Full Text] [Related]
9. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
Dyson AJ; Mackay AD
Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
[TBL] [Abstract][Full Text] [Related]
10. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
[TBL] [Abstract][Full Text] [Related]
11. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study Group.
FitzGerald JM; Chapman KR; Della Cioppa G; Stubbing D; Fairbarn MS; Till MD; Brambilla R
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):427-35. PubMed ID: 10069876
[TBL] [Abstract][Full Text] [Related]
12. Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses.
Arvidsson P; Larsson S; Löfdahl CG
J Asthma; 1993; 30(6):459-65. PubMed ID: 8244916
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
[TBL] [Abstract][Full Text] [Related]
14. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera MG; D'Amato G
Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
[TBL] [Abstract][Full Text] [Related]
15. Systemic effects of salbutamol and salmeterol in patients with asthma.
Bennett JA; Smyth ET; Pavord ID; Wilding PJ; Tattersfield AE
Thorax; 1994 Aug; 49(8):771-4. PubMed ID: 8091321
[TBL] [Abstract][Full Text] [Related]
16. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Mazza JA; Tashkin DP; Reed CE
Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
[TBL] [Abstract][Full Text] [Related]
18. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study].
Lebecque P; Vliers S; De Saint-Moulin T; Godding V
Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426
[TBL] [Abstract][Full Text] [Related]
19. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
Löfdahl CG; Svedmyr N
Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
[TBL] [Abstract][Full Text] [Related]
20. NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial.
Pasotti C; Capra A; Vibelli C
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):176-80. PubMed ID: 376459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
